Nevan C Elam
CIK 1314773 · View on SEC EDGAR ↗
First SEC filing: May 5, 2017 · Latest: May 5, 2017
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 15, 2025 | RZLT | P | 32,000 | $1.59 | $50,880 | 641,119 Direct | +5.25% | Acquired | 193.1% (price as of 2026-08-20) |
| March 27, 2025 | RZLT | P | 12,302 | $2.84 | $34,938 | 224,119 Direct | +5.81% | Acquired | 64.1% (price as of 2026-08-20) |
| Feb. 26, 2024 | RZLT | P | 5,000 | $1.68 | $8,400 | 7,817 Direct | +177.49% | Acquired | 177.4% (price as of 2026-08-20) |
| Dec. 28, 2023 | SVRA | S | 93,843 | $4.71 | $442,001 | 22,500 Direct | -80.66% | Disposed | 17.7% (price as of 2026-08-20) |
| Dec. 10, 2015 | RZLT | P | 76,923 | $1.95 | $150,000 | 76,923 Direct | — | Acquired | -95.2% (price as of 2026-08-20) |
| Feb. 9, 2015 | RZLT | S | 39,117 | — | — | 0 Indirect | -100.00% | Disposed | (price as of 2026-08-20) |
| Feb. 9, 2015 | RZLT | S | 842,949 | — | — | 0 Indirect | -100.00% | Disposed | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 2, 2025 | SVRA | Stock Option (Right to Buy) | Common Stock (5,860) | $1.46 | Dec. 15, 2025 | 5,860 | Disposed |
| Nov. 19, 2025 | RZLT | Employee Stock Option (Right to Buy) | Common Shares (186,000) | $10.16 | Nov. 19, 2035 | 186,000 | Acquired |
| June 10, 2025 | RZLT | Employee Stock Option (Right to Buy) | Common Shares (40,000) | $4.39 | June 10, 2035 | 40,000 | Acquired |
| Feb. 16, 2025 | RZLT | Employee Stock Option (Right to Buy) | Common Shares (120,000) | $4.61 | Feb. 16, 2035 | 120,000 | Acquired |
| Jan. 23, 2024 | RZLT | Employee Stock Options (Right to Buy) | Common Shares (340,000) | $1.02 | Jan. 23, 2029 | 340,000 | Acquired |
| Dec. 28, 2023 | SVRA | Stock Option (Right to Buy) | Common Stock (40,000) | $1.23 | Dec. 16, 2030 | 40,000 | Disposed |
| Dec. 28, 2023 | SVRA | Stock Option (Right to Buy) | Common Stock (12,000) | $1.59 | Dec. 20, 2029 | 12,000 | Disposed |
| Dec. 28, 2023 | SVRA | Stock Option (Right to Buy) | Common Stock (1,758) | $0.82 | July 24, 2024 | 1,758 | Disposed |
| Dec. 11, 2023 | SVRA | Stock Option (Right to Buy) | Common Stock (10,841) | $0.82 | Dec. 12, 2023 | 10,841 | Disposed |
| Dec. 13, 2022 | SVRA | Stock Option (Right to Buy) | Common Stock (40,000) | $1.51 | Dec. 13, 2032 | 40,000 | Acquired |
| Dec. 13, 2022 | SVRA | Stock Option (Right to Buy) | Common Stock (1,172) | $0.65 | Dec. 14, 2022 | 1,172 | Disposed |
| Dec. 14, 2021 | SVRA | Stock Option (Right to Buy) | Common Stock (40,000) | $1.11 | Dec. 14, 2031 | 40,000 | Acquired |
| Dec. 6, 2021 | SVRA | Stock Option (Right to Buy) | Common Stock (1,172) | $0.55 | Dec. 16, 2021 | 1,172 | Disposed |
| Aug. 18, 2021 | SVRA | Stock Option (Right to Buy) | Common Stock (2,288) | $0.52 | Aug. 30, 2021 | 2,288 | Disposed |
| Dec. 16, 2020 | SVRA | Stock Option (Right to Buy) | Common Stock (40,000) | $1.23 | Dec. 16, 2030 | 40,000 | Acquired |
| Dec. 15, 2020 | SVRA | Stock Option (Right to Buy) | Common Stock (2,930) | $0.52 | Dec. 17, 2020 | 2,930 | Disposed |
| Dec. 20, 2019 | SVRA | Stock Option (Right to Buy) | Common Stock (12,000) | $1.59 | Dec. 20, 2029 | 12,000 | Acquired |
| Feb. 4, 2019 | SVRA | Stock Option (Right to Buy) | Common Stock (21,682) | $0.19 | Feb. 20, 2019 | 21,682 | Disposed |
| Dec. 13, 2018 | SVRA | Stock Option (Right to Buy) | Common Stock (12,000) | $7.33 | Dec. 13, 2028 | 12,000 | Acquired |
| Dec. 17, 2017 | SVRA | Stock Option (Right to Buy) | Common Stock (3,750) | $15.21 | Dec. 17, 2027 | 3,750 | Acquired |
| Oct. 31, 2016 | RZLT | Stock Option (right to buy) | Common Stock | $1.20 | Oct. 31, 2026 | 3,500,000 | Acquired |
| Dec. 10, 2015 | RZLT | Series A Convertible Preferred Stock | Common Shares (76,923) | — | — | 76,923 | Acquired |
| Feb. 9, 2015 | RZLT | Warrant to Purchase Common Stock | Common Shares (39,117) | $1.25 | March 31, 2019 | 39,117 | Disposed |
| April 30, 2014 | RZLT | Stock Option (right to buy) | Common Stock (1,350,000) | $3.12 | April 30, 2019 | 1,350,000 | Acquired |
| March 31, 2014 | RZLT | Warrant to purchase common stock | Common Stock (234,700) | $1.25 | March 31, 2019 | 234,700 | Acquired |
| Feb. 25, 2008 | NKTR | Employee Stock Option | Common Stock (85,000) | $6.46 | Feb. 25, 2016 | 85,000 | Acquired |
| Dec. 21, 2007 | NKTR | Employee Stock Option | Common Stock (150,000) | $6.98 | Dec. 21, 2015 | 150,000 | Acquired |
| May 14, 2007 | NKTR | Restricted Stock Unit | Common Stock (1,400) | $0.01 | — | 1,400 | Disposed |
| April 2, 2007 | NKTR | Stock Option (Right to Buy) | Common Stock (40,000) | $13.02 | April 2, 2015 | 40,000 | Acquired |
| Sept. 1, 2006 | NKTR | Stock Option (Right to Buy) | Common Stock (12,000) | $17.52 | Sept. 1, 2014 | 12,000 | Acquired |
| March 10, 2006 | NKTR | Restricted Stock Unit | Common Stock (7,000) | $0.01 | — | 7,000 | Acquired |
| Jan. 17, 2005 | NKTR | Employee Stock Option (Right to Buy) | Common Stock (80,000) | $18.61 | Jan. 17, 2015 | 80,000 | Acquired |
| Jan. 17, 2005 | NKTR | Employee Stock Option (Right to Buy) | Common Stock (80,000) | $18.61 | Jan. 17, 2015 | 80,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 13 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 5, 2017 | SVRA | Stock Option (Right to Buy)→ Common Stock (21,682) | 21,682 | Direct |
| May 5, 2017 | SVRA | Stock Option (Right to Buy)→ Common Stock (2,930) | 2,930 | Direct |
| May 5, 2017 | SVRA | Stock Option (Right to Buy)→ Common Stock (2,288) | 2,288 | Direct |
| May 5, 2017 | SVRA | Stock Option (Right to Buy)→ Common Stock (1,172) | 1,172 | Direct |
| May 5, 2017 | SVRA | Stock Option (Right to Buy)→ Common Stock (1,172) | 1,172 | Direct |
| May 5, 2017 | SVRA | Stock Option (Right to Buy)→ Common Stock (10,841) | 10,841 | Direct |
| May 5, 2017 | SVRA | Stock Option (Right to Buy)→ Common Stock (1,758) | 1,758 | Direct |
| May 5, 2017 | SVRA | Stock Option (Right to Buy)→ Common Stock (5,860) | 5,860 | Direct |
| May 5, 2017 | SVRA | Stock Option (Right to Buy)→ Common Stock (10,841) | 10,841 | Direct |
| Feb. 8, 2013 | RZLT | Common Stock | 4,000,000 | Indirect |
| Feb. 8, 2013 | RZLT | Option to Purchase Common Stock→ Common Stock (3,500,000) | 3,500,000 | Direct |
| Jan. 19, 2005 | NKTR | Employee Stock Option (Right to Buy)→ Common Stock (80,000) | 80,000 | Direct |
| Jan. 19, 2005 | NKTR | Employee Stock Option (Right to Buy)→ Common Stock (80,000) | 80,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
NKTR
President and Head of the Pulmonary Business Unit| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2006 | $321,332 | — | — | — | $114,804 | — | $582 | $649,598 |
| 2005 | — | — | — | — | — | — | — | — |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $610,825 | $451,662 | — | — | — | — | — | $2,851,109 |
| 2022 | $515,000 | $378,750 | — | $6,862,960 | — | — | $24,590 | $7,781,300 |
| 2018 | $450,000 | — | — | $1,910,568 | — | — | $18,334 | $2,378,902 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.